Clinical Trial Update: Effect of Omalizumab in the Skin of Food Allergy Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of omalizumab on skin responses in patients with food allergy, including children; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Food Allergy

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: National Jewish Health | Conditions: Food Allergy, Food Allergy in Children | Phase 4 | Status: RECRUITING